AEVOLVE reinvents the health innovation ecosystem by creating a powerful channel that turns patients into active decision-makers, and redesigns the whole process of drug development financing to support small and medium innovators and favor speed to market.

It does this while creating access for investors through a securitization pathway designed for exposure to blockchain-derived assets.

It empowers patients as active stakeholders in the ecosystem through cryptoasset ownership, payer benefits and participation in a health

innovation marketplace, BioSpheres.

The protocol directs new capital towards groundbreaking medical and biotech projects through an alternative financing option via a first-of-its-kind wrapped certificate available via Swiss ISIN.

The AVEX Token

The AVEX token is the native transactional unit within the Aevolve Protocol. It is the primary asset for entry into the Aevolve ecosystem. Its role is defined under the rules

of the Aevolve Protocol.